Connect with us
European Gaming Congress 2024

Artificial Intelligence

Hedgehog Pathway Inhibitors Market to Grow at a CAGR of ~11.1% during 2023-2033; Market to Expand on the Back of the Rising Prevalence of Skin Cancer among the General Population across the Globe – Research Nester

Published

on

New York, Oct. 18, 2022 (GLOBE NEWSWIRE) — Research Nester has published a detailed market report on ‘Global Hedgehog Pathway Inhibitors Market’ for the forecast period, i.e. 2023 – 2033, which includes the following factors:

  • Market growth over the forecast period
  • Detailed regional synopsis
  • Market segmentation
  • Growth drivers
  • Profiling of key market players

Global Hedgehog Pathway Inhibitors Market Size:

The global hedgehog pathway inhibitors market is estimated to garner a revenue of nearly USD 1,722.3 Million by the end of 2033 by growing at a CAGR of around 11.1% over the forecast period, i.e., 2023 – 2033. Further, the market generated revenue of ~USD 601.1 Million in the year 2022. The growth of the market can be attributed primarily to the globally rising prevalence of skin cancer among the general population. For instance, a skin cancer diagnosis is expected to occur in one in five Americans by the age of 65. In the U.S., more than two people die from skin cancer every hour. Growing incidence of basal cell carcinoma (BCC) worldwide, increasing drug approvals by government authorities, exposure to UV rays among the global population are also expected to propel the market growth over the forecast period.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4417

Global Hedgehog Pathway Inhibitors Market: Key Takeaways

  • The North America region to gain the largest share of the revenue in the year 2022
  • The diagnostic procedures segment to dominate the revenue graph
  • Hospitals sub-segment remains prominent in the distribution channel segment

Increasing Global Prevalence of Cancer to Boost Market Growth

Increasing cases of cancer across the globe is estimated to be a prime factor to add to the growth of the global hedgehog pathway inhibitors market. According to the World Health Organization, nearly 10 million people died of cancer across the globe in 2020. The most recurrent cases of deaths because of cancer were lung cancer which caused 1.80 million deaths, colon and rectum cancer which caused 9,16,000 deaths, liver cancer which caused 8,30,000 deaths, stomach cancer which caused 7,69,000 deaths, and breast cancer which caused 6,85,000 deaths. Moreover, the rising investments in the R&D activities to continuously bring up more feasible solutions for medical procedures along with launch of new products are predicted to propel the global chemotherapy market over the forecast period.

Advertisement

In addition to this, growing incidence of basal cell carcinoma (BCC) worldwide is also estimated to propel the market growth over the forecast period. In terms of skin cancer, basal cell carcinoma (BCC) is the most commonly diagnosed form. Every year, approximately 3.5 million cases of BCC are diagnosed in the United States. Heavy chemical exposure increases the risk of developing carcinomas. As with indoor tanning, it can also lead to BCC as it reduces the synthesis of melanin. These risk factors are increasing the cases of BCC, which is anticipated to drive global hedgehog pathway inhibitors market growth during the forecast period. Hedgehog proteins are responsible for cell division, development, and survival. They are involved in organogenesis and stimulate the proliferation of adult stem cells. Furthermore, the need for minimally invasive procedures, rising chronic diseases, advanced healthcare technologies for cancer treatment, and investments provided by government are factors anticipated to drive global hedgehog pathway inhibitors market during the forecast period.

For more information in the analysis of this report, visit: https://www.researchnester.com/reports/hedgehog-pathway-inhibitors-market/4417

Global Hedgehog Pathway Inhibitors Market: Regional Overview

The global hedgehog pathway inhibitors market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa region.

Advanced Healthcare Facilities to Favor Market Growth in the North America Region

Advertisement

The market in the North America region captured the largest market share of 68% in the year 2022 backed by the increasing prevalence of basal and squamous cell skin cancers among population. A recent estimate indicates that approximately 5.5 million basal and squamous cell skin cancers are diagnosed each year in the United States. Further, the easy availability of better medical facilities, backed by the favorable medical policies in the region are estimated to fuel the regional hedgehog pathway inhibitors market’s growth. Moreover, increasing percentage of healthcare expense in overall GDP in the region is also expected to be an important factor to boost the growth of the market in the region.

Rapidly Increasing Population Expected to Boost Market Growth in the Asia Pacific Region

The Asia Pacific region in the global hedgehog pathway inhibitors market is estimated to witness modest growth over the forecast period on the back of a rising population in the particular region. According to the data by The World Bank, China and India are among the countries with the largest population, having 1.41 and 1.39 billion population respectively, in 2021, and their numbers are increasing on a yearly basis. Additionally, the rising cancer awareness among the population and increasing expenditure on research related to cancer in this region are further expected to boost the market growth. Moreover, the role of government in spreading awareness about the hedgehog pathway inhibitors are expected to boost the growth of the market in this region.

Get a Sample PDF of Hedgehog Pathway Inhibitors Market Report@ https://www.researchnester.com/sample-request-4417

The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in:

Advertisement
  • North America (U.S., Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)
  • Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Global Hedgehog Pathway Inhibitors Market, Segmentation by Indication

  • Diagnostic Procedures
  • Fundoplication Procedures
  • Radiofrequency Thermal Ablation
  • Magnetic Sphincter Augmentation

The diagnostic procedures segment held the largest market share of 66% in the year 2022. Diagnostic procedures help to identify the disease or condition and to determine the symptoms before and after the disease. The rising awareness of targeting the hedgehog pathway in cancer, and increasing oncology spending are anticipated to augment segment growth during the forecast period. For instance, in 2021, global oncology spending accounted to nearly USD 189 billion.

Global Hedgehog Pathway Inhibitors Market, Segmentation by Distribution Channel

  • Hospitals
  • Retail Pharmacies
  • Others

The hospitals sub-segment is expected to witness a modest growth in the global hedgehog pathway inhibitors market over the forecast period. The growth of this segment can be accredited to the existence of a huge patient pool in hospital facility. Moreover, rising healthcare expenditure per capita worldwide is also estimated to propel the growth of this segment. According to the data released by The World Bank, as of 2019, current health expenditure per capita among the global population was USD 1,121.97.

For more insights on the market share of various regions: https://www.researchnester.com/sample-request-4417

Global Hedgehog Pathway Inhibitors Market, Segmentation by Application

  • Basal Cell Carcinoma
  • Acute Myeloid Leukemia
  • Others

Few of the well-known market leaders in the global hedgehog pathway inhibitors market that are profiled by Research Nester are Mayne Pharma Group Limited, PellePharm, Inc., Pfizer, Inc., F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd., Inhibitor Therapeutics, Inc., MAX BioPharma, Inc., Infinity Pharmaceuticals Inc., Novartis AG, SANOFI, and others.
Do You Have Any Query Or Specific Requirement?

Submit Request for Proposal

Recent Developments in the Global Hedgehog Pathway Inhibitors Market

Advertisement
  • In September 2022, the usage of CytoReason’s artificial intelligence technology in Pfizer’s drug research initiatives has been expanded under a multi-year agreement between the two parties.
  • In January 2019, the businesses Phyton Biotech and PellePharm Inc. established a cooperative relationship to create a method based on plant cell culture that will allow PellePharm to produce the raw material for patidegib in the future utilizing renewable resources.

Explore Our Recent Related Reports:

Thoracic Vascular Stent Grafts Market Analysis by Type (Plastic Thoracic Vascular Stent Grafts, and Metal Thoracic Vascular Stent Grafts); and by End-User (Hospitals, Ambulatory Surgical Centers, Medical Centers, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Patient Lateral Transfer Market Analysis by Product (Air Assisted Transfer, Regular, Split Legs, and Half Mattress); by Usage (Disposable, Reusable, Sliding Sheets, and Accessories); and by End User (Hospitals, Ambulatory Surgical Center, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Oligonucleotide API Market Analysis by Product type {Reagents & Consumables, Equipment and Synthesized (DNA Oligonucleotides, RNA Oligonucleotides, and Others)}; by Marketing Status (Marketed, and Clinical Trials); and by End User (Pharmaceutical Companies and Biotechnology Companies) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Ophthalmic Tonometers Market Analysis by Product Type (Applanation, Pascal Dynamic Contour, Rebound, and Indentation); by Technology (Probe based, Electronic and Pneumatic); by Modality (Desktop, and Handheld); and by End User (Hospitals, Ophthalmic Diagnostic Centers, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Surgical Kits Market Analysis by Type (Disposable Surgical Kits, and Reusable Surgical Kits); and by Procedure (General Surgery, Cardiac Surgery, Orthopaedic Surgery, Urology, Ophthalmology, Neurosurgery, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2021-2031

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919

For More Update Follow: – LinkedIn | Twitter | Facebook | Xing

Advertisement

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

How AIoT shapes the future of mobility: Hikvision at ITS World Congress 2024

Published

on

how-aiot-shapes-the-future-of-mobility:-hikvision-at-its-world-congress-2024

HANGZHOU, China, Sept. 27, 2024 /PRNewswire/ — Hikvision made a significant impact at the ITS World Congress in Dubai with its captivating theme, “Embrace AIoT for safer, smarter, and greener mobility.” Its booth became a hub of innovation, where visitors explored AIoT solutions that are reshaping the transportation landscape, sparking deep conversations on the future of urban mobility.

Road safety revolution: harnessing AIoT for secure transportation
Hikvision’s commitment to road safety was on full display at its booth through the impressive array of AIoT solutions designed to create secure and reliable traffic environments. The company’s technology provides 24/7 traffic monitoring, ensuring continuous oversight of motor vehicles, non-motorized vehicles, pedestrians and environmental factors. This comprehensive, real-time information collection enables traffic managers to prevent accidents and enhance road safety. Among the showcased products was the 20 MP IR ANPR Checkpoint Capture Unit, renowned for its high-definition capture capabilities, bolstering traffic safety measures.
A standout innovation was the integration of advanced radar and camera technologies, ensuring uninterrupted, comprehensive detection even in adverse weather conditions. The Radar-Video Fusion Incident Detection Cameras, featured prominently in the product experience area, enable early detection and warning of potential hazards. They are particularly effective in challenging situations such as curved roads, blind spots at intersections, and obstacles beyond visual range.
Attendees also engaged with onboard monitoring products on the simulated bus, including dome network cameras, which is designed to enhance passenger safety. Driving assistance products, such as the Driver Status Monitor (DSM), were demonstrated to mitigate unsafe driving behaviors and ensure safer journeys.
Urban mobility redefined: smart traffic innovations
In the realm of smarter mobility, Hikvision showcased its multidimensional sensing technology, which integrates visible light sensors, infrared sensors, radar, and sonar. This technology expands perception capabilities, significantly improving traffic management and situational awareness. The use of AI-powered comprehensive sensing elevates incident monitoring and violation detection to unprecedented levels of accuracy and efficiency.
A major attraction was the Radar-Video Fusion TandemVu PTZ Camera, which integrates millimeter-wave radar with high-resolution cameras for extensive traffic detection and data analysis. AI-based algorithms combine these two systems to enhance target information, detecting up to 16 types of incidents. This leads to the development of a large-scale fusion model that merges spatial physical data with image semantic information. The result is ultra-long-range perception, achieving over 95% accuracy in vehicle trajectory detection. This robust system improves traffic violation management and optimizes traffic flow, significantly enhancing road efficiency.
At the simulated bus station, visitors observed how AI-assisted people counting automated the collection of passenger flow statistics at peak stop hours and bus line frequency during busy periods. Paired with smart bus stop digital signage, the solution improves bus service quality, operational efficiency, passenger experience, and overall public transport effectiveness.
Sustainable transportation: leading the charge for greener cities
Hikvision’s commitment to sustainable urban mobility was evident through its innovative green wave technology and eco-friendly checkpoint solutions. Green wave technology efficiently manages traffic flow to reduce congestion and lower carbon emissions, aligning with global sustainability goals. Visitors were particularly impressed by a case study showcasing a green wave solution implemented in Zhoushan, China. Over a stretch of 21 kilometers and 34 intersections, this main road cut travel times by 50%.
The use of DarkFighterX technology in checkpoint cameras also received significant attention. This technology senses both visible and invisible light, resulting in more accurate and realistic images. It enhances traffic violation enforcement efficiency while minimizing the need for high ambient light levels, thus reducing light pollution. The 9M DarkfightX ANPR Checkpoint Camera exemplified this dedication to environmental stewardship.
Frank Zhang, President of Hikvision MEA, remarked, “Hikvision supports sustainable urban planning by empowering traffic departments to address congestion and transportation challenges.” He further emphasized, “Our system’s openness fosters a secure and reliable platform for developing smart and green cities. Additionally, our solar technology is extensively utilized in remote areas, while our smart street lighting solutions reduce energy consumption by 20-30%, promoting intelligent urban transportation and advancing global sustainability objectives.”
Hikvision’s presence at the ITS World Congress in Dubai underscored its leadership in integrating AIoT technologies to drive safer, smarter, and greener mobility solutions. The engaging presentations and advanced product demonstrations captured significant attention from industry partners and customers, reaffirming the company’s role as a pioneer in shaping the future of urban transportation. As the world moves towards more intelligent and sustainable transportation systems, Hikvision remains at the forefront, embracing AIoT to create a safer, smarter, and greener future for all.
To find out more about Hikvision’s advanced traffic and public transport solutions, please explore the Hikvision official website.
Photo – https://mma.prnewswire.com/media/2516934/How_AIoT_shapes_future_mobility_Hikvision_ITS_World_Congress_2024.jpg

View original content:https://www.prnewswire.co.uk/news-releases/how-aiot-shapes-the-future-of-mobility-hikvision-at-its-world-congress-2024-302261298.html

Continue Reading

Artificial Intelligence

Anti-Drone Market worth $7.05 billion by 2029 – Exclusive Report by MarketsandMarkets™

Published

on

anti-drone-market-worth-$7.05-billion-by-2029-–-exclusive-report-by-marketsandmarkets™

DELRAY BEACH, Fla., Sept. 27, 2024 /PRNewswire/ — The global anti-drone market was valued at USD 2.16 billion in 2024 and is projected to reach USD 7.05 billion by 2029; it is expected to register a CAGR of 26.7% during the forecast period according to a new report by MarketsandMarkets™. Increasing government spending on counter-drone technologies, rising incidence of critical infrastructure security breaches by unauthorized drones, and surge in adoption of aerial remote sensing technologies to safeguard critical infrastructure are attributed to the demand for anti-drone.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=177013645
Browse in-depth TOC on “Anti-Drone Market” 178 – Tables61 – Figures253 – Pages
Anti-Drone Market Report Scope:
Report Coverage
Details
Market Revenue in 2024
$ 2.16 billion
Estimated Value by 2029
$ 7.05 billion
Growth Rate
Poised to grow at a CAGR of 26.7%
Market Size Available for
2020–2029
Forecast Period
2024–2029
Forecast Units
Value (USD Million/Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
By System Type, Application, Platform type, Vertical, and Region
Geographies Covered
North America, Europe, Asia Pacific, and Rest of World
Key Market Challenge
Vulnerability to hacking
Key Market Opportunities
Emphasis on improving unmanned aircraft systems technology
Key Market Drivers
Growing number of illicit activities
By System Type: Hybrid systems to account for the larger market share in the forecasted year.
The hybrid segment accounted for the largest share of the anti-drone market in 2029. The trends of integrating multiple anti-drone technologies are rising since they are most effective in detecting, tracking, and neutralizing drone threats. These systems merge electronic, kinetic, and lasers, providing a comprehensive defense solution against UAVs. Hybrid systems use electronic, kinetic, and laser-based countermeasures to offer optimum protection against drones. These systems are designed to detect, track, identify, categorize, and mitigate drones at operational wide ranges ranging from a few km up to tens of km.
By Platform: The ground-based segment accounted for the largest market share in the forecast year.
The ground-based segment will hold a major share of the anti-drone market in 2029. Many ground-based anti-drone systems use several electronic technologies, such as radar, IR sensors, acoustic systems, and RF & GNSS jammers. MESA radar solutions are used mostly for counter-UAS purposes, protecting critical infrastructure, military camps, and other security-sensitive sites from unauthorized drones. One such solution is EchoGuard, a ground-based airspace management solution that contains a software-defined 3D radar that can be specific to the site. This system can identify single or multiple off-chance drones, including swarms in unauthorized areas. They provide accurate and sustained airspace surveillance for the field of view (FOV) they are configured, and both human and AI-monitored visual checks. The system can be easily transported and integrated directly with the command-and-control centers or another identification sensor for portable use, and multiple units of the system can be combined to cover vast areas or lengths of borders. Major providers of ground-based counter-drone systems include companies like EchoDyne Corporation, DeTect, Meteksan Defense, and WhiteFox Defense. Acoustics-based Discovair G2 utilizes patented microphone arrays. With 128 interconnected microphone elements, the Discovair sensor units can establish azimuth and elevation to the target in real-time using advanced digital signal processing.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=177013645
By Region: Americas are expected to hold the largest share of the anti-drone market during the forecast period.
Americas is expected to capture the largest share in the anti-drone industry during the forecast period. The growth can be attributed to protecting crucial infrastructure in the region. Governments, particularly in the US, invest in anti-drone systems for military bases, borders, and critical infrastructure. For Instance, in April 2023, RTX secured a USD 237 million contract from the US Army to provide Ku-band Radio Frequency Sensors (KuRFS) and Coyote effectors. These systems are designed to detect and neutralize unmanned aircraft systems (UAS). The contract includes stationary and mobile systems and a specified quantity of effectors, all aimed at enhancing the Army’s operations within the US Central Command region.
Key Players-
The key companies offering anti-drone companies include RTX (US), Lockheed Martin Corporation (US), Leonardo S.p.A. (Italy), Thales (France), and IAI (Israel).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=177013645
Browse Adjacent Market: Semiconductor and Electronics Market Research Reports &Consulting
Related Reports: 
Drone Sensor Market Size, Share, Industry Growth & Trends by Sensor Type, Platform (VTOL Type, Fixed Wing Type, Hybrid Type), Application (Navigation, Collision Detection & Avoidance, Data Acquisition, Motion Detection, Power Monitoring), End Users and Region – Global Forecast to 2029
Smart Agriculture Market Size, Share, Statistics and Industry Growth Analysis Report by Offering (Hardware, Software, Services), Agriculture Type, Farm Size (Large, Medium, Small), Application (Precision Farming, Livestock Monitoring) and Region (America, Europe, Asia Pacific, Row) – Global Forecast to 2028
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact: Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: [email protected] Our Web Site: https://www.marketsandmarkets.com/Research Insight: https://www.marketsandmarkets.com/ResearchInsight/anti-drone-market.aspContent Source: https://www.marketsandmarkets.com/PressReleases/anti-drone.asp
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/anti-drone-market-worth-7-05-billion-by-2029—exclusive-report-by-marketsandmarkets-302260893.html

Continue Reading

Artificial Intelligence

CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review

Published

on

cluepoints-launches-medical-&-safety-review-(msr)-software-to-revolutionize-clinical-data-review

CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest addition to its enterprise software platform.
KING OF PRUSSIA, Pa., Sept. 27, 2024 /PRNewswire/ — CluePoints continues to transform clinical trial review and leverage its industry-leading software to enhance the interrogation, analysis and presentation of data with the launch of its latest application, Medical & Safety Review (MSR).

The tool simplifies and streamlines the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning, query management and full transparency over the data history. This not only improves efficiency and communication in medical oversight, but also elevates patient safety, differentiating MSR as a smarter and unique solution.
Designed by, and for Medical and Safety Reviewers, MSR converts the manual analysis of patient outcomes, which can be prone to inefficiency and error, into an accurate, efficient process. MSR tackles time-consuming study preparation for specific visualizations by featuring a comprehensive standard visualization library as well as the ability to copy and reuse dashboards across different studies, enabling the identification of outlying values, change tracking, and improved communication for smarter clinical trials.
Other benefits of MSR include:
Enhanced medical review efficiency and reduced human errors via automated checksReduced time spent by clinical and data management teams in reviewing dataImproved collaboration with integrated review workflows across departmentsEnsured record quality and accountability with comprehensive change trackingDriving faster decision making with the proactive detection of trends and safety issuesEnsuring regulatory compliance with rule-based detection and user assignmentsAndy Cooper, Chief Executive Officer at CluePoints, commented, “We are thrilled to announce the launch of Medical & Safety Review to our growing product offerings. MSR is the latest application addition to the CluePoints platform, which includes products such as Risk-Based Quality Management (RBQM) and our Site Profile & Oversight Tool (SPOT). Together, they provide a comprehensive approach to clinical trial optimization, enhancing data integrity, ensuring regulatory compliance, and accelerating drug development. The creation of MSR ensures a more streamlined review process while prioritizing patient safety at every step and empowers medical teams to swiftly identify outliers, track data changes, and improve communication.”
To learn more about CluePoints’ award-winning solutions, please visit www.cluepoints.com
About CluePoints
CluePoints is the premier Risk-Based Quality Management (RBQM) and Data Quality Oversight Software provider. We are leveraging the potential of Artificial Intelligence using Advanced Statistics and Machine Learning to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R2), CluePoints is deployed to support central and on-site monitoring, medical review, quality risk management and to drive a holistic Risk-Based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls and solution implementation, you now have everything you need to adhere with global regulatory guidance. The result is positive clinical development outcomes, increased operational efficiency, lower costs and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.
 

View original content:https://www.prnewswire.co.uk/news-releases/cluepoints-launches-medical–safety-review-msr-software-to-revolutionize-clinical-data-review-302260936.html

Continue Reading

Trending